Artículo de revista
In-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST
Fecha
2008Registro en:
Revista Medica de Chile, Volumen 136, Issue 2, 2018, Pages 143-150
07176163
00349887
Autor
Prieto, Juan Carlos
Sanhueza, Consuelo
Martínez, Nicolás
Nazzal, Carolina
Corbalán, Ramón
Cavada Chacón, Gabriel
Lanas, Fernando
Bartolucci, Jorge
Campos, Pabla
Gatica, Mario
Gaete, Pablo
Bustos, Carlos
Araya, María Virginia
Cotoras, Juan Antonio
Bonacic, Fernan
Institución
Resumen
Background: Primary angioplasty is considered the best reperfusion therapy in the treatment of ST-segment elevation myocardial infarction (STEMI). However, thrombolysis is the reperfusion method most commonly used, due to its wide availability, reduced costs and ease of administration. Aim: To compare in-hospital mortality in STEMI patients according to reperfusion therapy. Material and Methods: Patients admitted to Chilean hospitals participating in the GEMI network, from 2001 to 2005, with STEMI were included. They were divided in three groups: a) treated with thrombolytics, b) treated with primary angioplasty, c) without reperfusion procedure. In-hospital mortality according to gender, was analized in each group, using a logistic regression method, to assess risk factors associated with mortality. Results: We included 3,255 patients. Global mortality was 9.9% (7.5% in men and 16.7% in women, p <0.001). Mortality in patients treated with thrombolytics, was 10.2% (7.6% in men and 18.7